Dolby Laboratories (DLB) Tops Q3 EPS by 19c, Q4 EPS Tops Views

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.49, $0.19 better than the analyst estimate of $0.30. Revenue for the quarter came in at $231.5 million versus the consensus estimate of $235.29 million.

Dolby Laboratories sees Q4 2015 EPS of $0.43-$0.49, versus the consensus of $0.34. Dolby Laboratories sees Q4 2015 revenue of $230-240 million, versus the consensus of $244.86 million.

Dolby Laboratories sees FY2015 revenue of $970-980 million, versus the consensus of $986.31 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• HSBC upgrades EU stocks, downgrades EM on increased volatility
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge